Last updated on August 2017

Efficacy Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)


Brief description of study

Phase II clinical trial

Detailed Study Description

The aim of this trial is to compare the degree of efficacy, safety and tolerability of CG 428 cutaneous solution versus placebo on prevention of chemotherapy induced alopecia (CIA) in female patients with metastatic cancer treated with selected regimens inducing alopecia.

Clinical Study Identifier: NCT02919735

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Khalil KZ ZAMAN, PhD

CHUV Lausanne
Lausanne, Switzerland
  Connect »